{"transactions":[{"id":919306,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-04T21:27:11.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":10500,"price":9.1905,"value":96500.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 3/27/2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.92 to $9.55. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":62278,"source":{"system":"sec-edgar","filing":"0001945557-26-000004","document":"wk-form4_1770240428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000004/wk-form4_1770240428.xml","form_type":"4"}},{"id":924821,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":35334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to\nthe Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to\nthe Reporting person's continued service through such vesting date."}],"balance_after":35333,"derivative":{"underlying":"Common Stock","underlying_shares":35334},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924820,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to\nthe Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to\nthe Reporting person's continued service through such vesting date."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924819,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":8.86,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924818,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924817,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":35334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":72778,"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924816,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":3375,"price":8.8297,"value":29800.2375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/27/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.64 to $9.03. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37444,"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":924815,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:07.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":11333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":40819,"source":{"system":"sec-edgar","filing":"0001945557-26-000002","document":"wk-form4_1770070744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000194555726000002/wk-form4_1770070744.xml","form_type":"4"}},{"id":1267160,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2025-02-14T22:55:54.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":10500,"price":7.8597,"value":82526.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10/15/2024"}],"balance_after":29486,"source":{"system":"sec-edgar","filing":"0001437749-25-004069","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925004069/rdgdoc.xml","form_type":"4"}},{"id":1280354,"issuer":{"id":8505,"kind":"organization","name":"Shuttle Pharmaceuticals Holdings, Inc."},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-07T00:34:27.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":209790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 209,790 restricted stock units (\"RSUs\") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting."}],"balance_after":210004,"source":{"system":"sec-edgar","filing":"0001493152-25-005267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757499/000149315225005267/ownership.xml","form_type":"5/A","original_submission_date":"2025-02-03"}},{"id":1287517,"issuer":{"id":8505,"kind":"organization","name":"Shuttle Pharmaceuticals Holdings, Inc."},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T00:30:07.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":209790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 209,790 restricted stock units (\"RSUs\") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting."}],"balance_after":210004,"source":{"system":"sec-edgar","filing":"0001493152-25-004733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757499/000149315225004733/ownership.xml","form_type":"5"}},{"id":1287254,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287253,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287252,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":35333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":70667,"derivative":{"underlying":"Common Stock","underlying_shares":35333},"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1287251,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2025-02-03T22:22:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":35333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":39986,"source":{"system":"sec-edgar","filing":"0001437749-25-002627","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002627/rdgdoc.xml","form_type":"4"}},{"id":1661487,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Restricted Stock Unit","published_at":"2024-02-03T02:22:49.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. \t Grant to the Reporting Person of restricted stock units (\"RSU\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment."}],"balance_after":106000,"derivative":{"underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001437749-24-003036","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924003036/rdgdoc.xml","form_type":"4"}},{"id":1787007,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2023-09-06T21:11:54.000Z","date":"2023-09-05","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":5.129,"value":2564.5,"ownership":{"direct":true},"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001437749-23-025318","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923025318/rdgdoc.xml","form_type":"4"}},{"id":1841007,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2023-06-30T20:14:13.000Z","date":"2023-05-19","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.4157,"value":5415.7,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001437749-23-019035","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923019035/rdgdoc.xml","form_type":"4"}},{"id":1952070,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Common Stock","published_at":"2023-03-16T00:14:21.000Z","date":"2023-03-14","kind":"purchase","acquired":true,"shares":2000,"price":4.6089,"value":9217.8,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-23-006771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923006771/rdgdoc.xml","form_type":"4"}},{"id":2056417,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":67736,"kind":"person","name":"Schafer Joshua","position":1,"cik":"0001945557","reported_name":"Schafer Joshua","relationship":{"officer":true,"officer_title":"CCO & EVP, Bus. Development"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-12T02:49:17.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan (the \"Plan\"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":300000,"derivative":{"exercise_price":4.54,"expiration_date":"2033-01-08","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001437749-23-000915","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923000915/rdgdoc.xml","form_type":"4"}}]}